Imitrodast sodium

Drug Profile

Imitrodast sodium

Alternative Names: CS 518; Logran; RS 5186

Latest Information Update: 19 Oct 2000

Price : $50

At a glance

  • Originator Sankyo
  • Class Antiallergics; Antiasthmatics; Antiplatelets; Small molecules
  • Mechanism of Action Thromboxane A2 synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arterial thrombosis; Asthma; Coronary spasm; Ischaemic heart disorders

Most Recent Events

  • 19 Oct 2000 Discontinued-II for Coronary spasm in Japan (Unknown route)
  • 19 Oct 2000 Discontinued-II for Ischaemic heart disorders in Japan (Unknown route)
  • 19 Oct 2000 Discontinued-II for Arterial thrombosis in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top